Figure 5 (IMAGE)
Caption
Prognostic effects of NY-ESO-1 expression and serology with TCR repertoire features. (A) Kaplan?Meier plot evaluating PFS based on NY-ESO-1 expression and NY-ESO-1 serology, unadjusted for TCR features; p = 0.013. (B) Expected restricted mean PFS as a function of TIL/PBMC overlap. (C) Sorted bar chart of overlap across patients colored by expression/serology.
Credit
Correspondence to - Daan van de Kerkhof - daan.vd.kerkhof@catharinaziekenhuis.nl
Usage Restrictions
CCBY
License
Licensed content